Publications by authors named "Abdel Kareem Azab"

70Publications

Targeting E-selectin to Tackle Cancer Using Uproleselan.

Cancers (Basel) 2021 Jan 18;13(2). Epub 2021 Jan 18.

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA.

View Article and Find Full Text PDF
January 2021

Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile.

Int J Radiat Oncol Biol Phys 2020 Nov 27. Epub 2020 Nov 27.

Department of Radiation Oncology, Cancer Biology Division, Washington University in St Louis School of Medicine, St Louis, Missouri; Department of Biomedical Engineering, Washington University in St Louis McKelvey School of Engineering, St Louis, Missouri; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri. Electronic address:

View Article and Find Full Text PDF
November 2020

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma.

Cancers (Basel) 2020 Jan 28;12(2). Epub 2020 Jan 28.

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA.

View Article and Find Full Text PDF
January 2020

CXCR4-targeted PET imaging using Cu-AMD3100 for detection of Waldenström Macroglobulinemia.

Cancer Biol Ther 2020 1;21(1):52-60. Epub 2019 Oct 1.

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

View Article and Find Full Text PDF
October 2019

Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy.

Blood Cancer J 2019 08 20;9(9):68. Epub 2019 Aug 20.

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

View Article and Find Full Text PDF
August 2019

Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy.

Pharm Res 2019 Aug 7;36(10):144. Epub 2019 Aug 7.

Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, 4511 Forest Park Ave., Room 3103, St. Louis, MO, 63108, USA.

View Article and Find Full Text PDF
August 2019

PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.

Haematologica 2019 07 17;104(7):e310-e313. Epub 2019 Jan 17.

Department of Radiation Oncology, Cancer Biology Division, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA

View Article and Find Full Text PDF
July 2019

Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.

J Pharm Sci 2018 03 21;107(3):922-933. Epub 2017 Nov 21.

Department of Radiation Oncology, Washington University in Saint Louis School of Medicine, St. Louis, Missouri 63110; Siteman Cancer Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri 63110. Electronic address:

View Article and Find Full Text PDF
March 2018

Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma.

Transl Oncol 2017 Aug 29;10(4):632-640. Epub 2017 Jun 29.

Department of Radiation Oncology, Cancer Biology Division, Washington University in Saint Louis School of Medicine, Saint Louis, MO 63108, USA. Electronic address:

View Article and Find Full Text PDF
August 2017

Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.

Leuk Lymphoma 2017 12 16;58(12):2916-2925. Epub 2017 May 16.

a Department of Radiation Oncology, Cancer Biology Division , Washington University in Saint Louis School of Medicine , St. Louis , MO , USA.

View Article and Find Full Text PDF
December 2017

Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.

Eur J Haematol 2017 Jun 28;98(6):529-541. Epub 2017 Mar 28.

Cancer Biology Division, Department of Radiation Oncology, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA.

View Article and Find Full Text PDF
June 2017

The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma.

Leuk Res 2017 04 12;55:23-32. Epub 2017 Jan 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, USA; Department of Pediatric Hematology/Oncology, Seattle Children's Hospital, 4800 Sand Point Way, Seattle, WA, USA; Department of Pediatrics, University of Washington, 1959 NE Pacific St., Seattle, WA, USA.

View Article and Find Full Text PDF
April 2017

Direct measurement of hypoxia in a xenograft multiple myeloma model by optical-resolution photoacoustic microscopy.

Cancer Biol Ther 2017 02 3;18(2):101-105. Epub 2017 Jan 3.

a Department of Biomedical Engineering , Washington University in St. Louis , St. Louis , MO , USA.

View Article and Find Full Text PDF
February 2017

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy.

Hypoxia (Auckl) 2015 11;3:83-92. Epub 2015 Dec 11.

Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine in St Louis, MO, USA.

View Article and Find Full Text PDF
December 2015

Drug Delivery Approaches for the Treatment of Cervical Cancer.

Pharmaceutics 2016 Jul 20;8(3). Epub 2016 Jul 20.

Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA.

View Article and Find Full Text PDF
July 2016

A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma.

Pharm Res 2016 10 11;33(10):2530-9. Epub 2016 Jul 11.

Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, 4511 Forest Park Ave., Room 3103, St. Louis, Missouri, 63108, USA.

View Article and Find Full Text PDF
October 2016